The short version
LillyDirect (Zepbound vials) is a manufacturer direct-to-patient channel for the FDA-approved product. As of the September 12, 2026 build, for tirzepatide its lowest 12-month all-in total is $4,938 (month-to-month plan, verified), shown as a brand benchmark rather than ranked against compounded plans. Verification status: verified.
The numbers, plan by plan
- Tirzepatide (brand, vial, month-to-month plan): $299 per month, rising to $449 per month at the highest published dose. Status: verified, checked September 4, 2026. Self-pay Zepbound vials: $299 at 2.5 mg (initiation dose), $399 at 5 mg, $449 at 7.5 to 15 mg under the Self Pay Journey offer when refill-timing requirements are met; regular prices if conditions are missed are $499 at 7.5 mg and $699 at 10, 12.5 and 15 mg. Card terms stated through December 31, 2026.
Fees and what the price includes
The published price includes the medication and clinical care and shipping, with no separate membership fee. Shipping is included. A consultation fee is billed separately. The medication price rises with dose, so our 12-month total uses the titration model described on the methodology page.
How this pricing structure plays out over a year
Because the price rises with dose, roughly nine of the first twelve months are billed at the higher tier on the label's schedule, and every month after that.
Compared with the field
On tirzepatide, LillyDirect (Zepbound vials)'s lowest twelve-month total of $4,938 is $3,438 above the lowest (Trimi, $1,500) and above the median of $3,000 across 31 ranked providers. On the value score it scores 47 against 92 for NexLife, the best-scoring provider; the gap comes from cost, transparency, flexibility, care.
Pharmacy, coverage and cancellation
The provider reports serving all fifty states. Dispensing: brand. Named pharmacies: Lilly-contracted mail-order pharmacy. Commitment: month-to-month. Cancellation: No subscription; order per fill.
Questions to ask LillyDirect (Zepbound vials) before paying
Ask, in writing: Will my dosing instructions state the concentration of the vial you actually ship, and will you reissue them if it changes? A provider that answers all of these promptly is operating in the open; one that will not name its pharmacy has answered the most important question.
What works
FDA-approved tirzepatide with manufacturer quality control. No membership; pay per fill. Manufacturer prices fell substantially in late 2025.
What to weigh against it
Self-pay prices remain two to three times compounded prices at maintenance doses. Vials require drawing up doses with a syringe rather than using a pen. Prescription and clinical care must be arranged separately.
Who should choose LillyDirect (Zepbound vials)
Patients who want FDA-approved tirzepatide and can afford manufacturer self-pay pricing. A patient with insurance coverage for Zepbound or Wegovy should compare the copay route first; a patient who wants a verified flat all-in price with month-to-month flexibility should compare the best overall provider on our value score; and any patient should ask which pharmacy fills the prescription before paying.
Is LillyDirect (Zepbound vials) legitimate? What we can verify
LillyDirect (Zepbound vials) operates as a telehealth prescriber: a licensed clinician reviews an intake and issues a prescription, and a pharmacy fills it. That is the lawful model, and it is the same model every provider on this site uses; the questions that separate a legitimate operation from a risky one are whether the price is published before intake, whether the pharmacy is named, whether the prescription documents a clinical reason for a compounded product, and whether the company answers questions in writing. Its prices were verified against its own pages, which is the first test. It names its dispensing pharmacy (Lilly-contracted mail-order pharmacy), which lets a patient verify the license. It is named in manufacturer litigation over compounded-tirzepatide marketing, which is a fact worth knowing and not a finding against it. We have no evidence of a scam, and we do not use the word for any provider that prescribes on a valid prescription and ships from a licensed pharmacy; LegitScript certification, BBB profiles and state-board actions are not yet captured in our data and are listed as checks a patient can make.
LillyDirect (Zepbound vials) complaints and reputation
We have not yet analyzed public reviews of LillyDirect (Zepbound vials) for complaint patterns; the reputation index explains the method (shipping, billing and refund, provider access, support, and dosing-instruction complaints as shares of recent reviews). Until it is run, the useful checks are Trustpilot and the Better Business Bureau for volume and recency, and Reddit threads for the specific failure modes patients describe: shipments that arrive warm, charges after cancellation, clinicians who do not answer, and dosing sheets that do not match the vial.
Fees, HSA/FSA and promotions
No introductory or promotional price is recorded; we do not publish promotional codes. HSA/FSA eligibility is not captured; most telehealth GLP-1 programs can issue itemized receipts for FSA/HSA reimbursement, but eligibility of compounded medication depends on the plan administrator. A consultation fee is billed separately.
Consultation, labs, refills and shipping
Consultation type (video, phone or asynchronous questionnaire) is not captured in our data; most compounded-GLP-1 telehealth intakes are asynchronous with a clinician follow-up, and a patient who needs a video visit should ask. Lab requirements are not captured; many providers accept recent labs and some require none for compounded GLP-1s, while brand-name and insurance-first programs more often require them. Refill process is not captured; ask how a dose increase is requested, how many days before the next dose a refill ships, and whether a new visit is required. Shipping is included; transit is typically one to three days by carrier after the pharmacy fills.
Alternatives to LillyDirect (Zepbound vials)
Alternatives worth comparing: NexLife has the highest value score for tirzepatide (91) at $1,668 for twelve months; SnagRx has the lowest twelve-month total ($1,428, verified).
Update history
November 6, 2025 — Zepbound vials (2.5 mg / 5 mg / 7.5–15 mg, Self Pay Journey): $349 / $499 / $499 → $299 / $399 / $449 (price change; source: Lilly coverage and savings page; verified 2026-09-04). February 25, 2025 — Zepbound vials (2.5 mg / 5 mg; 7.5 and 10 mg added): $399 / $549 → $349 / $499; $499 higher doses (price change; source: Eli Lilly announcement). August 27, 2024 — Zepbound vials (2.5 mg / 5 mg): $399 / $549 (price change; source: Eli Lilly announcement). Full log on the price history page.
How we verified this
Lilly's coverage and savings page verifies the self-pay vial tiers ($299 at 2.5 mg, $399 at 5 mg, $449 at 7.5–15 mg under conditions, with $499/$699 regular prices) and states the program terms through December 31, 2026. Verified against the provider's own pages on 2026-09-04 (first-party verification pass).